Table 9.
Calculated sample size requirement to detect an improvement in insulin sensitivity based on a baseline serum 25-hydroxyvitamin D concentration of 40 ng/mL (100 nmol/L) and a power of 0.80 and alpha of 0.05
|
Initial serum 25-hydroxy-vitamin D concentration
|
Estimated insulin sensitivity index(μM/min/m2/pM)
|
Improvement in insulin sensitivity index with postintervention Serum 25-hydroxyvitamin D concentration 40 ng/mL (100 nmol/L)
|
Diabetes reduction based on the Diabetes Prevention Program
|
Sample size
|
|
|
ng/mL
|
nmol/L
|
||||
| 10 | 25 | 4.1326 | 0.8664 | 0.4361 | 340 |
| 15 | 37 | 5.4144 | 0.4246 | 0.2118 | 1602 |
| 20 | 50 | 6.2812 | 0.2280 | 0.1121 | 5934 |
| 25 | 62 | 6.8674 | 0.1232 | 0.0589 | 21878 |
| 30 | 75 | 7.2638 | 0.0619 | 0.0278 | 99260 |
| 35 | 87 | 7.5319 | 0.0241 | 0.0086 | 1041162 |